Non-Current Liabilities - US Warrant Liability (Tables)

12 Months Ended

Jun. 30, 2023

Schedule of US Warrant Non-Current Liabilities


	Consolidated
	June 30, 2023			June 30, 2022
	A$			A$

Opening balance		131,896			722,966
Fair value movements		(131,896	)		(591,070	)
Exercising of warrants*		—			—

Closing Balance		—			131,896

In July 2017, the Group completed its first US capital raise after it entered into a securities purchase agreement with certain accredited investors for the Group to issue American Depositary Shares (ADSs) and Warrants of Immutep for cash consideration totaling A$6,561,765. In this private placement, the Company agreed to issue unregistered warrants to purchase up to 1,973,451 of its ADSs. The warrants were issued with an exercise price of US$2.50 per ADS, were exercisable immediately and expired on January 5, 2023. The warrants do not confer any rights to dividends or a right to participate in a new issue without exercising the warrant. During the financial year 2022, 1,347,211 of these warrants were exercised at US$2.49 each and 206,507 of these warrants remained as at June 30, 2022. During the financial year 2023 no warrants were exercised, and 206,507 warrants expired on January 5, 2023.